SCHEMBL22019064

SCHEMBL22019064

Clc1cccc2c3cccc(-c4ccccc4)c3n(-c3ccccc3)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.47
▸ MAPK14 Q16539 1/20 0.42
▸ HSD11B1 P28845 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ ATM Q13315 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ESR1 P03372 3/20 0.37
▸ NPC1 O15118 5/20 0.37
▸ RAB9A P51151 5/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAP4K4 O95819 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ PDGFRA P16234 1/20 0.36
▸ LTK P29376 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ MAPK8 P45983 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ CDK5 Q00535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21666163 0.89 KDM4E (0.45) CYP2A6KDM4EATML3MBTL1NPC1
SCHEMBL17885092 0.86 CYP2A6 (0.37) CYP2A6MAPK14ATMESR1NPC1
SCHEMBL17885076 0.86 MAPK14 (0.40) CYP2A6MAPK14KDM4EATML3MBTL1
SCHEMBL19213252 0.84 KDM4E (0.43) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL19213271 0.82 KDM4E (0.45) CYP2A6KDM4EATML3MBTL1ESR1
SCHEMBL26191626 0.81 MAPK14 (0.45) CYP2A6MAPK14KDM4EATML3MBTL1
SCHEMBL28690869 0.81 KDM4E (0.49) CYP2A6MAPK14KDM4EATML3MBTL1
SCHEMBL21157068 0.81 AVPR1A (0.41) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL17853075 0.80 ABCG2 (0.41) KDM4EATML3MBTL1SMN1; SMN2MEN1
SCHEMBL21042125 0.80 ALDH1A1 (0.47) KDM4EATML3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-01-20 — — US disclosed
WO-2020101169-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2020-05-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR51E2, OR10J3 CYP2A6 1577/4885MAPK14 1805/4885HSD11B1 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback